TD Cowen Lowers P3 Health Partners (NASDAQ:PIII) Price Target to $0.25

P3 Health Partners (NASDAQ:PIII) had its price objective cut by TD Cowen from $0.90 to $0.25 in a report issued on Wednesday,Benzinga reports. They currently have a hold rating on the stock.

P3 Health Partners Price Performance

Shares of NASDAQ PIII opened at $0.21 on Wednesday. The company has a market cap of $76.19 million, a price-to-earnings ratio of -0.25 and a beta of 1.15. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 1.11. The stock has a 50-day moving average price of $0.37 and a two-hundred day moving average price of $0.49. P3 Health Partners has a 12 month low of $0.19 and a 12 month high of $1.78.

Insider Transactions at P3 Health Partners

In other P3 Health Partners news, major shareholder Pacific Founders Ugp I. Chicago acquired 80,000 shares of the company’s stock in a transaction on Wednesday, September 4th. The shares were purchased at an average cost of $0.49 per share, with a total value of $39,200.00. Following the completion of the purchase, the insider now owns 76,625,438 shares of the company’s stock, valued at approximately $37,546,464.62. This represents a 0.10 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In the last 90 days, insiders have bought 400,000 shares of company stock worth $205,600. Company insiders own 17.86% of the company’s stock.

Institutional Investors Weigh In On P3 Health Partners

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC increased its stake in shares of P3 Health Partners by 188.1% during the 2nd quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock worth $50,000 after purchasing an additional 73,000 shares during the last quarter. Sanders Morris Harris LLC lifted its holdings in P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock worth $64,000 after purchasing an additional 20,000 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock valued at $398,000 after acquiring an additional 550,925 shares during the period. Emfo LLC grew its position in shares of P3 Health Partners by 39.8% during the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after purchasing an additional 406,418 shares in the last quarter. Finally, Armistice Capital LLC bought a new position in P3 Health Partners in the 2nd quarter worth about $3,557,000. Hedge funds and other institutional investors own 7.75% of the company’s stock.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.